Extrapolating from semaglutide and tirzepatide data is reasonable given shared molecular characteristics (large protein-based structures, poor oral bioavailability), but it is not the same as having direct evidence
While it is considerably cheaper, L-carnitine does not have the same bioavailability as acetyl L-carnitine (ALC) and has not been used in studies on mitochondrial decline
Here is how it usually works
At GoalBMI Wellness, Karla works with eligible patients exploring GLP-1 and GIP weight loss programs, peptide therapy, hormone optimization, metabolic wellness, and personalized treatment plans through secure telehealth consultations
[1] But the trait that really sets it apart is its effect on BDNF: a second study by the same group found Semax raises brain-derived neurotrophic factor in the brain, [2] which behaves much like a nerve growth factor and drives plasticity
Another major piece of the chronic illness puzzle is the profound overlap between dysautonomia, specifically Postural Orthostatic Tachycardia Syndrome (POTS), and connective tissue disorders like hypermobile Ehlers-Danlos Syndrome (hEDS)
